Who
Claude Maraoui
President & CEO
Company insider
Files Form 4 as: President & CEO, Journey Medical.
In numbers
- Trades disclosed
- 24
- Buys
- 2
- Sells
- 10
- Bought
- $100K
- Sold
- $938K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Jul 2022
- Last trade
- 22 Apr 2026
- Last filed
- 24 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Apr 2026filed 24 Apr 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —49,277 at $0.00 | filing |
| 22 Apr 2026filed 24 Apr 2026 | DERM Journey Medicaloption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,915 at $0.00 | filing |
| 22 Apr 2026filed 24 Apr 2026 | DERM Journey Medicaloption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,915 at $0.00 | filing |
| 22 Apr 2026filed 24 Apr 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —49,277 at $0.00 | filing |
| 25 Aug 2025filed 26 Aug 2025 | DERM Journey Medicaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,250,000 at $0.00 | filing |
| 25 Aug 2025filed 26 Aug 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code M | $88K1,250,000 at $0.07 | filing |
| 25 Aug 2025filed 26 Aug 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code F | $81K10,877 at $7.47 | filing |
| 17 Jun 2025filed 20 Jun 2025 | DERM Journey Medicaloption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,915 at $0.00 | filing |
| 17 Jun 2025filed 20 Jun 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —49,277 at $0.00 | filing |
| 2 May 2025filed 5 May 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $33K4,834 at $6.84 | filing |
| 11 Mar 2025filed 11 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $247K49,271 at $5.01 | filing |
| 7 Mar 2025filed 10 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $75K14,905 at $5.01 | filing |
| 6 Mar 2025filed 10 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $129K25,551 at $5.04 | filing |
| 5 Mar 2025filed 5 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $93K18,147 at $5.13 | filing |
| 4 Mar 2025filed 5 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $146K28,901 at $5.04 | filing |
| 3 Mar 2025filed 5 Mar 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Sold | $122K23,508 at $5.19 | filing |
| 1 May 2024filed 16 Apr 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 22 Mar 2024filed 25 Mar 2024 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Bought | $35K10,000 at $3.48 | filing |
| 3 Jan 2024filed 16 Apr 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 6 Sep 2023filed 8 Sep 2023 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Bought | $66K26,044 at $2.52 | filing |
News
Head to Head Survey: Collegium Pharmaceutical (NASDAQ:COLL) versus Journey Medical (NASDAQ:DERM)DERM · dailypolitical.com · 22 Oct 2026Journey Medical (NASDAQ:DERM) Downgraded by Wall Street Zen to "Hold"DERM · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Claude Maraoui; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.